HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Backs Proposed SPF Cap For Sunscreens, In Break From Rivals

This article was originally published in The Rose Sheet

You may also be interested in...



EWG To FDA Commish: Sunscreen SPFs Require ‘Urgent’ Investigation

The Environmental Working Group renews its call for a cap on SPF values at 50+, asking FDA to investigate whether anti-inflammatory ingredients added to sunscreen formulations are boosting SPFs without providing meaningful protection against UV damage. The NGO also recommends changes to the agency’s SPF testing requirements to improve the accuracy of labeled SPF claims.

California Court Upholds Fed Preemption In J&J Sunscreen Labeling Cases

A California appeals court affirms that sunscreen labeling falls within the purview of FDA, rejecting plaintiff allegations that J&J/Neutrogena sunscreen labeling – fully compliant with federal regulations – is potentially misleading nonetheless in violation of California law.

Senators Push FDA For SPF Cap, Spray Sunscreen Review

A group of Senators has sent a letter to FDA Commissioner Margaret Hamburg asking the agency to resolve sunscreen issues that remain in regulatory limbo. Led by Sen. Jack Reed, D-RI, the Senators urge FDA to establish a UV protection cap and thoroughly review spray sunscreens for safety.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017842

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel